Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial

NCATS Open Data2021-12-31 更新2026-08-08 收录

抗原免疫原性评估

疫苗临床试验

数据链接：

https://doi.org/10.1101/2021.12.23.21267374 数据链接链接失效反馈

官方服务：

资源简介：

Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial

创建时间：

2021-12-25

Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled Trial

资源简介：

相关数据集